Filing Details

Accession Number:
0000711377-17-000027
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-02 08:18:25
Reporting Period:
2017-09-29
Accepted Time:
2017-10-02 08:18:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-29 10,000 $36.07 879,212 No 4 M Direct
Common Stock Disposition 2017-09-29 10,000 $77.06 869,212 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-09-29 10,000 $0.00 10,000 $36.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
272,425 2018-08-30 No 4 M Direct
Footnotes
  1. Options were granted 8-30-2013, have five year lives, and vest in equal 20% annual installments on the first five anniversary dates of the grant